Pharma & Drug Safety

Health Advisory: New World Screwworm Parasitic Fly

The Texas Department of State Health Services (DSHS) issued a health advisory on September 26, 2025, to raise awareness about the New World screwworm (NWS), a parasitic fly. While no current cases are reported in Texas, healthcare providers are urged to remain vigilant for potential travel-related cases and report suspected infestations immediately.

Texas DSHS Prohibits Sale of Consumable Hemp to Minors

The Texas Department of State Health Services (DSHS) has adopted emergency rules prohibiting the sale of consumable hemp products to individuals under 21 years of age. These rules are effective immediately and implement Governor Greg Abbott's executive order GA-56, with potential penalties including license revocation for violations.

Texas Pertussis Cases Surge; CDC Recommends Vaccines

The Texas Department of State Health Services issued a health alert regarding a significant surge in pertussis (whooping cough) cases, with over 3,500 reported in 2025, a fourfold increase from the previous year. The CDC recommends vaccination for all ages, with particular emphasis on pregnant women and those around newborns.

Texas DSHS Issues Measles Alert for West Texas

The Texas Department of State Health Services issued a notice on January 27, 2026, regarding three confirmed cases of measles in non-Texas residents who traveled through West Texas. The alert urges the public to remain vigilant and provides potential exposure locations and dates.

Guidance on Psychiatric Evaluation and Discharge Practices

The New York State Office of Mental Health and Department of Health have issued updated joint guidance on psychiatric evaluation and discharge practices for individuals with behavioral health conditions. This update aligns with recent changes to state regulations and provides guidance for emergency departments, comprehensive psychiatric emergency programs, and inpatient psychiatric units.

MHRA Restricts Chikungunya Vaccine IXCHIQ Use

The MHRA has introduced additional restrictions on the use of the Chikungunya vaccine IXCHIQ. The vaccine is now restricted to adults aged 18-59 without specific pre-existing health conditions, following reports of serious adverse reactions, including fatalities. Healthcare professionals must conduct a benefit-risk assessment before administration.

Pharmacy Commission Meeting Minutes and Actions

The Connecticut Commission of Pharmacy met on October 30, 2024, approving a new pharmacy application with modifications, a pharmacy remodel, and issuing fines totaling $3,000 to Walgreens for violations related to pharmacy closures and compounding standards. The commission also approved reciprocity and new applications.

Pharmacy Commission Meeting Agenda - October 30, 2024

The Connecticut Pharmacy Commission meeting agenda for October 30, 2024, outlines discussions on new pharmacy applications, remodels, pharmacy manager appointments, and reciprocity interviews. The agenda also includes requests for new non-resident pharmacy applications and updates on previously approved or denied applications.

Pharmacy Commission Meeting Minutes - Approvals and Enforcement

The Connecticut Commission of Pharmacy approved new pharmacy premises and several pharmacy remodels during its November 20, 2024 meeting. The Commission also initiated an enforcement action against Walgreens #02410 for alleged violations related to pharmacy manager changes and operating without a manager.

Pharmacy Commission Meeting Agenda

The Connecticut Pharmacy Commission met on November 20, 2024, to review 20 new pharmacy applications, including new and non-resident pharmacies, and address two legal cases. The agenda also included discussions on pharmacy remodels and reciprocity interviews.